Cortisol Levels in Saliva and Their Association with Cognitive Decline and Alzheimer’s Disease in Elderly Individuals
Overview
This study investigates the relationship between diurnal salivary cortisol levels and cognitive decline, including incident Alzheimer's disease (AD), in a diverse cohort of older adults.
Background
Alzheimer's disease is a significant global health issue, particularly as populations age, leading to increased disability and mortality. Understanding biomarkers that reflect systemic processes influencing cognitive aging is crucial for developing prevention strategies.
Data Highlights
No specific numerical data or trial results were provided in the source material.
Key Findings
Salivary cortisol reflects biologically active cortisol levels, making it valuable for studying stress and cognitive aging.
Higher peripheral cortisol levels are associated with hippocampal atrophy and increased risk of Alzheimer's disease.
Prior studies have shown mixed results regarding cortisol's association with cognitive outcomes in healthy older adults.
This study characterized diurnal salivary cortisol in nearly 4000 older adults, focusing on its association with cognitive decline and incident AD.
Racial differences in diurnal cortisol patterns and cognitive implications were evaluated, particularly among Black and White participants.
Clinical Implications
The findings suggest that salivary cortisol may serve as a useful biomarker for understanding cognitive decline and Alzheimer's disease risk. Clinicians should consider the role of stress physiology in cognitive assessments and potential interventions.
Conclusion
This research underscores the need for further exploration of salivary cortisol as a biomarker in cognitive aging and Alzheimer's disease, particularly in diverse populations.
